The PARADIGM-HF study in HFrEF patients treated with sacubitril/valsartan (ARNi) showed reduced PINP levels compared to the ACE inhibitor enalapril treated group after 8 months [93]. The gene discussed is ACE; the disease is hydrops fetalis.